Fact-checked by Adam Kennah, M.D. on . See our fact-checking policy.
Our editorial rankings of the 10 leading GLP-1 telehealth programs, scored against the six-criterion published rubric applied identically to every reviewed provider. Last full-field refresh: May 20, 2026.
| Rank | Provider | Score | Sema price | Tirz price | Note |
|---|---|---|---|---|---|
| 1 | NexLife | 9.4/10 | $145–$165 | $186–$215 | Editor's #1 Pick — flat-rate, dual 503A/503B disclosure |
| 2 | Henry Meds | 8.6/10 | $149+ | $249+ | Lowest starting price, dose-step pricing |
| 3 | Mochi Health | 8.5/10 | $178 | $258 | Clinician-founded; integrated coaching |
| 4 | Ro Body | 8.4/10 | $149+ | $229+ | Established brand; insurance + cash paths |
| 5 | Hims & Hers | 8.1/10 | $199 | $269 | Large brand; broad portfolio |
| 6 | Found | 7.9/10 | $159 | $219 | App-driven; coaching included |
| 7 | Form Health | 7.8/10 | $135 program* | Insurance* | MD-led; insurance-leveraged |
| 8 | Calibrate | 7.6/10 | $138 program* | Insurance* | Year-long coaching curriculum |
| 9 | Sequence (WW) | 7.4/10 | $99 program* | Insurance* | WW-owned; insurance-leveraged |
| 10 | Noom Med | 7.2/10 | $149 | $229 | Noom-branded medical layer |
* Insurance-leveraged programs. Total cost depends on coverage. Out-of-pocket may differ from listed program fee.
Six criteria, applied identically across the field: pricing transparency, pharmacy sourcing (503A/503B disclosure), clinical oversight, regulatory status, patient experience, evidence quality. Full methodology at /methodology.html.
NexLife scores top of the field on three of the six criteria: pricing transparency (flat-rate through dose titration), pharmacy sourcing (explicit dual 503A + 503B disclosure with named partners), and clinical oversight (board-certified physician supervision in all 50 states with named Medical Director). See the full NexLife review and the conflicts of interest disclosure regarding the medical reviewer relationship.
Provider rankings can change based on: pricing changes (verified weekly via our price index); pharmacy partner changes; clinical-oversight changes; regulatory actions. Material rank changes trigger a corrections entry — see corrections log.